Received Jun 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
she experienced significant injection site pain, redness, and swelling (over 100 mm) down the injection side of her arm; she experienced significant injection site pain, redness, and swelling (over 100 mm) down the injection side of her arm; she experienced significant injection site pain, redness, and swelling (over 100 mm) down the injection side of her arm; This non-serious case was reported by a consumer via sales rep and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: she experienced significant injection site pain, redness, and swelling (over 100 mm) down the injection side of her arm), injection site erythema (Verbatim: she experienced significant injection site pain, redness, and swelling (over 100 mm) down the injection side of her arm) and injection site swelling (Verbatim: she experienced significant injection site pain, redness, and swelling (over 100 mm) down the injection side of her arm). The outcome of the injection site pain, injection site erythema and injection site swelling were resolved. The reporter considered the injection site pain, injection site erythema and injection site swelling to be possibly related to Shingrix. The company considered the injection site pain, injection site erythema and injection site swelling to be possibly related to Shingrix. Additional Information: GSK Receipt Date: 11-JUN-2026 The patient experienced significant injection site pain, redness, and swelling (over 100 mm) down the injection side of her arm and this lasted for approximately 1 week. Patient saw a pharmacist and was monitored throughout. The symptoms had since subsided. The patient/reporter believes this was related to the vaccine. The batch number was not provided, and we are unable to contact the reporter.